Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study

Mora Murri1, Isabel Leiva, Juan Miguel Gomez-Zumaquero

  • 1Biomedical Research Laboratory, Virgen de la Victoria Hospital (FIMABIS), Campus de Teatinos s/n, Málaga, 29010, Spain.

BMC Medicine
|February 26, 2013
PubMed

Insights

Type 1 diabetes in children is linked to significant gut microbiota changes, including altered levels of key bacteria like Bifidobacterium and Lactobacillus. These gut bacteria alterations may correlate with glycemic control in diabetic children.

Area of Science:

  • Microbiology
  • Pediatric Endocrinology
  • Gastroenterology

Background:

  • Type 1 diabetes (T1D) onset in rats is associated with distinct gut bacterial communities.
  • This study investigates the hypothesis that T1D in humans is also linked to specific gut microbiota compositions.

Purpose of the Study:

  • To quantify and compare gut microbiota composition between children with T1D and healthy children.
  • To determine the relationship between the gut microbiota of children with T1D and their glycemic levels.

Main Methods:

  • A case-control study involving 16 children with T1D and 16 healthy children.
  • Fecal bacteria composition analyzed using polymerase chain reaction-denaturing gradient gel electrophoresis and real-time quantitative polymerase chain reaction.

Main Results:

  • Children with T1D exhibited significantly altered gut microbiota compared to healthy children, including decreased Actinobacteria and Firmicutes, and increased Bacteroidetes.
  • Specific genera like Clostridium and Bacteroides were increased, while Lactobacillus and Bifidobacterium were decreased in children with T1D.
  • The Firmicutes/Bacteroidetes ratio negatively correlated with plasma glucose, while Clostridium positively correlated with plasma glucose in the T1D group.

Conclusions:

  • This study is the first to demonstrate a link between T1D and gut microbiota compositional changes in children.
  • Alterations in Bifidobacterium, Lactobacillus, Clostridium, and the Firmicutes/Bacteroidetes ratio may be associated with glycemic control in T1D.
  • Reduced levels of gut bacteria crucial for gut integrity were observed in children with T1D, suggesting potential therapeutic targets for T1D management.
Abstract

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...